Just Now
Fit For Your Company:
UnknownEnter your company details to see if Peter T. Lansbury is a good fit as an investor for your company.
Enter Your CompanyPeter T. Lansbury
Chief Scientific Officer at Lysosomal Therapeutics
Boston, United States
Invests in All Sectors
Seed, Early, Growth, Pre-Seed, Series A
Upgrade to Funden Lite to see Peter T. Lansbury's email address
Upgrade to Funden Lite to see Peter T. Lansbury's LinkedIn profile
